Current and Future Roles of Adjuvant Endocrine Therapy in the Management of Early Carcinoma of the Breast
- 1 January 1996
- book chapter
- Published by Springer Nature
- Vol. 140, 215-226
- https://doi.org/10.1007/978-3-642-79278-6_24
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Should clinicians be concerned about the carcinogenic potential of tamoxifen?European Journal Of Cancer, 1994
- Peri-operative hormones and prognosis in breast cancerEuropean Journal Of Cancer, 1994
- Alternative mechanisms of action of anti-oestrogensBreast Cancer Research and Treatment, 1994
- Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancerEuropean Journal Of Cancer, 1994
- Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancerThe Lancet, 1992
- Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progressionMolecular Endocrinology, 1992
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancerJournal of Steroid Biochemistry, 1985